Aneela Majeed
@AneelaMajeed5
Followers
197
Following
223
Media
42
Statuses
237
Transplant ID, Associate Staff, Cleveland Clinic, Ohio. Former Fellow @ Stanford University
Cleveland, OH
Joined January 2020
1 in 4 CAR-T patients face CMV reactivation, doubling mortality risk, and fueling relapse. @NausheenAhmedMD @GorslineChelsea @AneelaMajeed5 @faiza_HKhan @KUcancercenter
1
8
20
The ID family had a warm and empowering evening connecting with the incredible Women in Medicine team from the Integrated Health Institute! ✨🙌#WomenInMedicine #WomenInInfectiousDisease #IDCommunity
@ClevelandClinic
0
4
6
Now presenting Dr. Aneela Majeed from @ClevelandClinic “Dynamic Infection Management Tactics in TCE and CAR-T” National #ICE_T #mmsm #MedEd #myeloma #MedTwitter #USMIRC @USMIRCNEWS @OncoAlert #سرطان_الدم #المايلوما @CancerNetwrk
0
4
9
Final panel group picture for the supportive Care and ALL session: Rebecca Gonzalez PharmD Dr. Sunil Abhyanker Dr. Aneela Majeed Dr. Muhammad Nashatizadeh National #ICE_T #msmm #MedEd #myeloma #MedTwitter #USMIRC @USMIRCNEWS @OncoAlert #سرطان_الدم #المايلوما @CancerNetwrk
0
2
7
Thank you, Dr. Majeed for hosting us and extending such a warm welcome to our new ID fellows! #infectiousdisease #IDXposts
1
1
10
BAL Aspergillus PCR study in @TheTxIDJournal for identifying IPA in SOT - ⬇️ sensitivity ~ 67 % - ⬆️ specificity 98% (95% CI 93%–99%) in identifying IPA in SOT recipients. Added by @AneelaMajeed5 to "Fungal Diagnostics"📁 https://t.co/gK4r5XO7jg
0
15
42
Antimicrobial Stewardship in Patients With Cancer: Interventions and Future Directions to Combat the Rise of Antimicrobial Resistance | @JCOOP_ASCO Thank you @AneelaMajeed5 for the excellent editorial https://t.co/PNQAnaqOWx
1
6
21
Today, for our Tuesday Transplant Lecture, we had Dr. Majeed discuss endemic fungal infections in transplant patients—a crucial topic for our immunocompromised hosts!#TID #FungalInfections #IDTwitter
1
4
8
Wonderful to be part of one of the best hospitals in the world @ClevelandClinic
https://t.co/3nWkEHtr4P
@Newsweek
0
8
45
How Should We Manage the Impact of Antimicrobial Resistance in Patients With Cancer? An Oncological and Infectious Disease Specialist Point of View | @JCOOP_ASCO
https://t.co/CH2wgQIvJn
@OncoAlert @JCO_ASCO
0
11
22
Clevelanders seem happier in Hawaii - weather effect ☀️
1
0
2
Post BMT outcomes- high incidence of VRE in GVHD pts. > 60% mortality within 1 month with sepsis. Post cart vaccination response is variable less than 1/3 pts respond to pneumococcal vaccine High crp> 14 days can predict BSI in post car-t.
2
2
10
ID doc is not a support staff but Cancer specialist 🙂 Great discussion by ID transplant on CMV, HHV6, mold- risks vs benefits of antimicrobial. Extend cmv ppx to day 200 in high risk HSCT Cmv surveillance 2-6 weeks in high risk Cart, no EBV or Adeno surveillance needed
0
0
3
Tandem ASTCT 2025 Hawaii Great sessions- ID track New guidelines
0
0
8
Antimicrobial effects on outcome of cart and HSCT by effecting microbiome. Anaerobic sparing antibiotics better for neutropenic fever Increase fiber Domination of enterococcus is associated with lethal GVHD
0
0
1
For today’s ID Grand Rounds, we had Dr. Faiz Anwer discuss immunotherapy and CAR-T cell. He made such a complex topic easy to understand! Great talk and valuable insights . #IDGrandRounds #Immunotherapy #CARTCells
1
2
27
0
1
1
Added by @AneelaMajeed5 to the 📂 - CMV▶️Letermovir - BMT-specific ID - GVHD #Letermovir ppx still better than old pre-emptive therapy! https://t.co/98eSHRNWKB
This study evaluated letermovir for cytomegalovirus (CMV) prophylaxis in alemtuzumab-treated allogeneic #HSCT patients. Results showed reduced CMV risk and lower chronic #GVHD incidence within 100 days, with no impact on survival or acute GVHD rates. https://t.co/ON7E5KT2M5
0
8
11